Biblio
Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia. Front Immunol. 2023;14:1182251.
Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation. Transpl Immunol. 2022:101596.
. Stem Cell-Based Therapies for Ischemic Stroke. Biomed Res Int. 2014;2014:468748.
. Therapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct. Arch Med Sci. 2013;9(3):561-568.
.